New insider Mcpherron Aviva claimed ownership of 50,050 shares (SEC Form 3)
$OFIX
Medical/Dental Instruments
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 05/01/2025 |
3. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 50,050(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (Right to Buy) | (2) | 06/17/2031 | Common Stock | 68,638 | $12.57 | D | |
| Employee Stock Option (Right to Buy) | (3) | 03/03/2032 | Common Stock | 41,908 | $16.98 | D | |
| Explanation of Responses: |
| 1. Consists of 2,549 shares of Common Stock directly owned by Reporting Person and 47,501 unvested restricted stock units of which 9,944 units will vest on June 17, 2025, 5,889 units will vest on March 3, 2026, 9,944 units will vest on June 17, 2026, 5,889 units will vest on March 3, 2027, 9,945 units will vest on June 17, 2027 and 5,890 units will vest on March 3, 2028. |
| 2. The options shall vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date on which the average closing price of the Company's common stock over a consecutive thirty (30) calendar day period has been equal to or greater than 150% of the exercise price or (ii) with respect to one-third (1/3rd) of the shares of Stock covered hereby on the first anniversary of the grant date and one-twelfth (1/12th) of the shares of Stock covered hereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the grant date. |
| 3. The options shall vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the grant date. |
| /s/ J. Andres Cedron, attorney-in-fact | 05/09/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||